Novel anti‐fatty acid synthase compounds with anti‐cancer activity in HER2+ breast cancer
- 25 October 2010
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1210 (1) , 86-92
Abstract
Fatty acid synthase (FASN) expression and activity has emerged as a common phenotype in most human carcinomas, including breast cancer, and its expression is tightly linked to HER2 signaling pathways. The development of inhibitors of FASN activity has consequently appeared as a novel antitarget modality for treating cancer. However, the clinical use of FASN inhibitors, such as cerulenin, C75, and epigallocatechin 3‐gallate (EGCG), is limited by anorexia and induced body weight loss or by its low in vivo potency and stability. Here, we summarize the design and development of G28UCM, the lead‐compound of a novel family of synthetic FASN inhibitors, with both in vitro and in vivo activity in a human breast cancer model of FASN+ and HER2+.Keywords
This publication has 34 references indexed in Scilit:
- Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancerLaboratory Investigation, 2008
- Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung TumorsClinical Cancer Research, 2008
- Selective Inhibition of Fatty Acid Synthase for Lung Cancer TreatmentClinical Cancer Research, 2007
- Inhibition of Fatty Acid Synthase Induces Endoplasmic Reticulum Stress in Tumor CellsCancer Research, 2007
- Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitorThe FASEB Journal, 2006
- Increased lipogenesis in cancer cells: new players, novel targetsCurrent Opinion in Clinical Nutrition and Metabolic Care, 2006
- Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosisMolecular Cancer Therapeutics, 2006
- RNA Interference–Mediated Silencing of the Acetyl-CoA-Carboxylase-α Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer CellsCancer Research, 2005
- PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBPOncogene, 2005
- On the Origin of Cancer CellsScience, 1956